CARCINOMAS | Synaptophysin | Chromogranin_A | Insulin | Glucagon | Gastrin | Somatostatin | MUC4 | CD56 | B-Catenin | PGP 9.5 | CK19 | CA19-9 | bcl-10 | E-Cadherin | CD10 | Maspin | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pancreatic Adenocarcinoma | – | – | – | – | – | – | + | – | – | – | + | + | – | +/- | + | ||
Neuroendocrine Tumor | + | + | +/- | +/- | +/- | +/- | – | + | + | + | +/- | +/- | – | – | – | – | |
Solid Pseudopapillary | + | – | – | – | – | + | + | – | – | – | – | + | – | ||||
Pancreatic Ductal Carcinoma | – | – | – | – | – | – | +/- | - | + | - | +/- | +/- | + | ||||
Acinic Cell Carcinoma | – | – | – | – | – | – | + | - | + | +/- | + | + | +/- | - | |||
Pancreatoblastoma | – | + | – | – | – | – | – | + | + | – | – | – | + | – | – | + | |
Benign Pancreas | + | + | + | + | – | + | – | – | + | – | – | – | – | – | - |
CARCINOMAS | GFAP | Neurofilament | Synaptophysin | S-100 | CK Cocktail | PR | EMA | Vimentin | NGFR | INI-1 | SOX2 |
---|---|---|---|---|---|---|---|---|---|---|---|
Astrocytoma | +/- | – | – | + | – | – | – | + | + | + | + |
Glioblastoma | + | – | – | + | – | – | – | + | – | + | + |
Oligodendroglioma | – | – | – | + | – | – | – | + | – | + | + |
Ependymoma | +/- | – | – | + | – | – | – | -/+ | + | + | + |
Choroid Plexus Carcinoma | -/+ | – | + | + | + | – | – | - | + | ||
Central Neurocytoma | -/+ | – | +/- | – | – | – | – | – | + | + | + |
Neuroblastoma | +/- | + | +/- | +/- | – | – | – | – | + | + | – |
Pineocytoma | -/+ | – | + | + | – | – | – | - | + | - | |
Meningioma | – | – | – | – | – | + | + | + | – | + | – |
Schwannoma | + | – | – | + | -/+ | – | – | + | + | - | |
Rhabdoid Tumors | – | +/- | +/- | + | + | + | - | ||||
Metastatic Carcinoma | – | – | – | – | + | -/+ | + | -/+ | – | - |
CARCINOMAS | RCC | CD10 | PAX-2 | Vimentin | Ksp-Cadherin | Parvalbumin | CD117 | Ep-CAM | Caveolin-1 | PAX-8 | pVHL |
---|---|---|---|---|---|---|---|---|---|---|---|
Clear Cell Renal Cell Carcinoma | + | + | + | + | – | – | – | – | + | + | + |
Chromophobe RCC | – | – | – | – | + | + | + | + | + | + | + |
Oncocytoma | – | – | – | – | + | + | + | – | +/- | + | + |
CARCINOMAS | CK7 | CK20 | ER/PR | CD44 | CA15-3 | CA19-9 | p63 | CK5 | CD117 |
---|---|---|---|---|---|---|---|---|---|
Infiltrating Ductal Carcinoma | + | – | + | + | + | – | – | – | – |
Adenoid Cystic Carcinoma | + | – | – | – | + | + | + | + | + |
CARCINOMAS | GCDFP-15 | Mammaglobin | CA15-3 | Caveolin-1 | PSA | TTF-1 | Napsin A |
---|---|---|---|---|---|---|---|
Breast Carcinoma | + | + | + | + | – | – | – |
Lung Carcinoma | – | – | – | – | – | + | + |
Prostate Carcinoma | – | – | – | +/- | + | – | – |
CARCINOMAS | Chromogranin A | Synaptophysin | PTH | S-100 | TTF-1 | Calcitonin | PAX-8 |
---|---|---|---|---|---|---|---|
Parathyroid Tumors | + | + | + | – | – | – | – |
Follicular Cell Tumors | – | – | – | +/- | + | – | + |
Medullary Thyroid Carcinoma | + | + | – | – | + | + | + |
CARCINOMAS | Calretinin | Inhibin | CD99 | CK7 | EMA | Vimentin | MART-1 |
---|---|---|---|---|---|---|---|
Granulosa Cell Tumors | + | + | + | – | – | + | + |
Sertoli-Leydig Cell Tumors | + | + | -/+ | + | – | + | + |
Gynandroblastoma | + | + | |||||
Gonadoblastomas | + | + | + | – | – | + | – |
1st Trimester | 2nd Trimester | 3rd Trimester | ||||
---|---|---|---|---|---|---|
Trophoblastic Cells | hCG | hPL | hCG | hPL | hCG | hPL |
Cytotrophoblast | – | – | – | – | – | – |
Intermediate Trophoblast | 1-24% | 25-49% | -/+ | 50-74% | 1-24% | 1-49% |
Syncytiotrophoblast | 75% | 1-24% | 25-49% | 50-74% | 1-24% | 75% |
Trophoblastic Proliferations | p57 | hCG | PLAP | hPL | CK Cocktail | Vimentin |
---|---|---|---|---|---|---|
Partial Mole | + | weak, diffuse | + | weak, diffuse | strong, diffuse | – |
Complete Mole | – | strong, diffuse | weak, focal | weak, focal | strong, diffuse | – |
Choriocarcinoma | – | strong, diffuse | weak, focal | weak, focal | strong, diffuse | – |
Placental Site Tumor | strong, focal | strong, diffuse | strong, diffuse | strong, diffuse | strong, diffuse |
CARCINOMAS | CK7 | CK20 | S-100 | EMA | GCDFP-15 | CD15 |
---|---|---|---|---|---|---|
Merkel Cell Carcinoma | – | + | – | + | – | – |
Sebaceous Tumor | + | – | – | – | – | + |
Apocrine Tumor | – | - | +/- | + | +/- | |
Eccrine Tumor | - | + | + | – | - |
Breast Lesion | GCDFP-15 | Mammaglobin | B-Catenin | E-Cadherin | CK, 34bE12 | p120 |
---|---|---|---|---|---|---|
Lobular | + | + | – | – | + | + (cytoplasmic) |
Ductal | + | + | + (membranous) | + | – | + (membranous) |
Meningiomas | Claudin 1 | EMA | S-100 | CD34 | GFAP |
---|---|---|---|---|---|
Meningothelial Meningioma | + | + | – | – | – |
Atypical Meningioma | + | + | – | + | – |
Fibrous Meningioma | – | + | + | – | – |
Solitary Fibrous Tumor | – | – | – | + | – |
Meningeal Hemangiopericytoma | – | – | – | + | – |
Schwannoma | +/- | – | + | – | + |
Carcinomas | D2-40 | FLI-1 | CD31 | CK Cocktail | CD10 |
---|---|---|---|---|---|
Metastatic Renal Cell Carcinoma | – | – | – | + | + |
Hemangioblastoma | + | + | + | – | – |
Carcinomas | PAX-8 | WT1 | CA-125 | CEA | pVHL |
---|---|---|---|---|---|
Ovarian Carcinoma, Serous | + | + | + | + | – |
Ovarian Carcinoma, Mucinous | – | – | – | – | – |
Ovarian Endometrioid Carcinoma | + | – | + | – | – |
Ovarian Clear Cell Carcinoma | + | – | + | – | + |
Tumors | CK, LMW | CK, HMW | S-100 | CEA | Vimentin |
---|---|---|---|---|---|
Melanoma | – | – | + | – | + |
Paget’s Disease | + | – | -/+ | + | – |
Bowen’s Disease | + | + | – | – | – |
Carcinomas | CK Cocktail | Ep-CAM | EMA | bcl-2 |
---|---|---|---|---|
Basal Cell Carcinoma | + | + | – | + |
Squamous Cell Carcinoma | + | – | + | – |
Tumors | Claudin 1 | EMA | S-100 | GLUT1 |
---|---|---|---|---|
Perineurioma | + | + | – | + |
Neurofibroma | + | + | – | – |
Carcinomas | Calponin | SM Myosin | p63 |
---|---|---|---|
Breast Carcinoma in-situ | + | + | + |
Infiltrating Breast Carcinoma | – | – | – |
Tumors | pVHL | S-100 | Maspin |
---|---|---|---|
Pancreas | + | – | – |
Pancreatic Intraepithelial Neoplasia | – | + | + |
Pancreatic Adenocarcinoma | – | + | + |